• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见的LIPC基因变体中存在的C-480T和G-216A替代会降低肝脂肪酶启动子活性,而上游刺激因子会增加其活性。

Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor.

作者信息

Botma G J, Verhoeven A J, Jansen H

机构信息

Department of Biochemistry, Cardiovascular Research Institute (COEUR), Erasmus University Rotterdam, PO Box 1738, 3000 DR, Rotterdam, The Netherlands.

出版信息

Atherosclerosis. 2001 Feb 15;154(3):625-32. doi: 10.1016/s0021-9150(00)00478-0.

DOI:10.1016/s0021-9150(00)00478-0
PMID:11257263
Abstract

The common -216G-->A and -480C-->T substitutions in the promoter region of the human hepatic lipase (LIPC) gene show high allelic association, and are correlated with decreased hepatic lipase activity and increased high-density lipoprotein cholesterol levels. To test the functionality of these substitutions, CAT-reporter assays were performed in HepG2 cells. LIPC (-650/+48) but not (-650/+61) promoter constructs showed transcriptional activity. LIPC (-650/+48) constructs with both -216A and -480T exhibited significantly lower promoter activity (-45%) than the wild-type form. Activities of -289/+48 constructs were not significantly affected by the -216G-->A substitution. The -480C/T site lies within a binding region for Upstream Stimulatory Factor (USF). Gel-shift assays showed that the binding affinity of USF protein for HL specific oligonucleotides was decreased four-fold by the -480C-->T substitution. However, promoter activity of the -650/+48 constructs was not significantly affected by the -480C-->T substitution alone. Co-transfection of HepG2 cells with USF(43) cDNA yielded a similar dose-dependent increase in activity of all -650/+48 constructs; the absolute difference in promoter activity increased but the relative difference between the variant promoter forms was maintained. Our studies demonstrate that the common LIPC promoter variation is functional, which explains the association of the -480T allele with a lower hepatic lipase activity in man.

摘要

人类肝脂酶(LIPC)基因启动子区域常见的-216G→A和-480C→T替换显示出高度的等位基因关联,并且与肝脂酶活性降低和高密度脂蛋白胆固醇水平升高相关。为了测试这些替换的功能,在HepG2细胞中进行了CAT报告基因检测。LIPC(-650/+48)启动子构建体显示出转录活性,而(-650/+61)则没有。同时含有-216A和-480T的LIPC(-650/+48)构建体的启动子活性比野生型形式显著降低(-45%)。-289/+48构建体的活性不受-216G→A替换的显著影响。-480C/T位点位于上游刺激因子(USF)的结合区域内。凝胶迁移实验表明,-480C→T替换使USF蛋白与HL特异性寡核苷酸的结合亲和力降低了四倍。然而,-650/+48构建体的启动子活性单独不受-480C→T替换的显著影响。将HepG2细胞与USF(43) cDNA共转染,所有-650/+48构建体的活性都产生了类似的剂量依赖性增加;启动子活性的绝对差异增加,但变异启动子形式之间的相对差异保持不变。我们的研究表明,常见的LIPC启动子变异具有功能,这解释了-480T等位基因与人类较低肝脂酶活性的关联。

相似文献

1
Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor.常见的LIPC基因变体中存在的C-480T和G-216A替代会降低肝脂肪酶启动子活性,而上游刺激因子会增加其活性。
Atherosclerosis. 2001 Feb 15;154(3):625-32. doi: 10.1016/s0021-9150(00)00478-0.
2
Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations.加拿大三个群体中LIPC基因启动子的基因变异与血浆脂蛋白之间不存在关联。
Atherosclerosis. 1999 Sep;146(1):153-60. doi: 10.1016/s0021-9150(99)00113-6.
3
Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.葡萄糖通过上调上游刺激因子1和2来增加HepG2肝细胞中肝脂酶的表达。
Diabetologia. 2008 Nov;51(11):2078-87. doi: 10.1007/s00125-008-1125-6. Epub 2008 Aug 30.
4
Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol.肝脂酶基因启动子中的常见变异与较低的肝脂酶活性、漂浮低密度脂蛋白水平以及较高的高密度脂蛋白2胆固醇水平相关。
Arterioscler Thromb Vasc Biol. 1998 Nov;18(11):1723-9. doi: 10.1161/01.atv.18.11.1723.
5
Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression.固醇调节元件结合蛋白抑制上游刺激因子刺激的肝脂酶基因表达。
Atherosclerosis. 2005 Mar;179(1):61-7. doi: 10.1016/j.atherosclerosis.2004.10.027. Epub 2004 Dec 18.
6
A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women.一种肝脂酶基因启动子多态性可减弱女性中随着腹部脂肪增加而出现的肝脂酶活性升高。
Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2701-7. doi: 10.1161/01.atv.19.11.2701.
7
A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes.肝脂酶基因(LIPC - 480C>T)中一种常见的启动子多态性与1型糖尿病患者冠状动脉钙化增加有关。
Diabetes. 2002 Apr;51(4):1208-13. doi: 10.2337/diabetes.51.4.1208.
8
A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity.
J Lipid Res. 2002 Oct;43(10):1595-601. doi: 10.1194/jlr.m200046-jlr200.
9
Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.USF、Ikaros和Sp蛋白在人类还原型叶酸载体B启动子转录调控中的作用。
Biochem J. 2004 Oct 15;383(Pt 2):249-57. doi: 10.1042/BJ20040414.
10
Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant.
Diabetes Care. 2003 Feb;26(2):427-32. doi: 10.2337/diacare.26.2.427.

引用本文的文献

1
Functional Haplotype of Induces Triglyceride-Mediated Suppression of HDL-C Levels According to Genome-Wide Association Studies.根据全基因组关联研究,[基因名称]的功能性单倍型诱导甘油三酯介导的高密度脂蛋白胆固醇水平抑制。 (原文中“Induces”前缺少具体基因名称,翻译时用[基因名称]代替)
Genes (Basel). 2021 Jan 22;12(2):148. doi: 10.3390/genes12020148.
2
The -514C>T polymorphism in the LIPC gene modifies type 2 diabetes risk through modulation of HDL-cholesterol levels in Mexicans.LIPC基因中-514C>T多态性通过调节墨西哥人的高密度脂蛋白胆固醇水平来改变2型糖尿病风险。
J Endocrinol Invest. 2021 Mar;44(3):557-565. doi: 10.1007/s40618-020-01346-x. Epub 2020 Jul 2.
3
The cross-sectional study of hepatic lipase SNPs and plasma lipid levels.
肝脂肪酶单核苷酸多态性与血脂水平的横断面研究。
Food Sci Nutr. 2020 Jan 13;8(2):1162-1172. doi: 10.1002/fsn3.1403. eCollection 2020 Feb.
4
A novel upstream transcription factor 1 target gene that regulates adipogenesis.一种调节脂肪生成的新型上游转录因子1靶基因。
Biochem Biophys Rep. 2019 Aug 6;20:100676. doi: 10.1016/j.bbrep.2019.100676. eCollection 2019 Dec.
5
Reduced dietary nitrogen with a high Lys:CP ratio restricted dietary N excretion without negatively affecting weaned piglets.降低日粮氮水平并提高赖氨酸与粗蛋白比例可限制断奶仔猪的日粮氮排泄,且不会对其产生负面影响。
Anim Nutr. 2019 Jun;5(2):115-123. doi: 10.1016/j.aninu.2019.01.001. Epub 2019 Feb 2.
6
Dietary fat modulation of hepatic lipase variant -514 C/T for lipids: a crossover randomized dietary intervention trial in Caribbean Hispanics.饮食脂肪对肝脂肪酶变体 -514 C/T 与脂质的调节作用:加勒比西班牙裔人群中的一项交叉随机饮食干预试验。
Physiol Genomics. 2017 Oct 1;49(10):592-600. doi: 10.1152/physiolgenomics.00036.2017. Epub 2017 Sep 22.
7
Association between two common polymorphisms (single nucleotide polymorphism -250G/A and -514C/T) of the hepatic lipase gene and coronary artery disease in type 2 diabetic patients.肝脂肪酶基因两个常见多态性(单核苷酸多态性-250G/A和-514C/T)与2型糖尿病患者冠状动脉疾病之间的关联。
Adv Biomed Res. 2016 Feb 15;5:27. doi: 10.4103/2277-9175.176366. eCollection 2016.
8
Multiple Hepatic Regulatory Variants at the GALNT2 GWAS Locus Associated with High-Density Lipoprotein Cholesterol.GALNT2全基因组关联研究位点的多个肝脏调控变异与高密度脂蛋白胆固醇相关。
Am J Hum Genet. 2015 Dec 3;97(6):801-15. doi: 10.1016/j.ajhg.2015.10.016.
9
The -514C/T Polymorphism of Hepatic Lipase Gene among Iranian Patients with Coronary Heart Disease.伊朗冠心病患者肝脂酶基因 -514C/T 多态性研究
Iran J Public Health. 2012;41(1):59-65. Epub 2012 Jan 31.
10
A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS.全基因组范围内对改变 microRNA 种子序列的 SNPs 的检测确定了 GWAS 中的功能候选物。
BMC Genomics. 2011 Oct 13;12:504. doi: 10.1186/1471-2164-12-504.